LAURA STALLINGS: Open Payments
NPI 1174157424 · MAUMELLE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$948 in 53 payments from 15 companies in 2025. Trend: 2023 $626 · 2024 $1,129 · 2025 $948
Food & beverage: $948
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 11 | $209 |
| ABBVIE INC. | 13 | $165 |
| Supernus Pharmaceuticals, Inc. | 11 | $160 |
| Eisai Inc. | 1 | $124 |
| AstraZeneca Pharmaceuticals LP | 2 | $41 |
| Phathom Pharmaceuticals, Inc. | 4 | $39 |
| Janssen Pharmaceuticals, Inc | 2 | $33 |
| Lundbeck LLC | 2 | $31 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $26 |
| SANOFI-AVENTIS U.S. LLC | 1 | $26 |
Products named: Auvelity, VRAYLAR, Qelbree, Leqembi, AIRSUPRA, VOQUEZNA, SPRAVATO, VYEPTI.
Industry payments across AR — which companies pay providers there.
